Expression data from patient-derived pancreatic cancer organoids with gene engineering

Expression data from ovarian cancer with CHSY1 knockdown

Redefining the molecular rejection states in 3230 heart transplant biopsies: relationships to parenchymal injury and graft survival

gene expression profiling

Side-population trophoblasts from first and third trimester pregnancies

Endothelial dysfunction in NR2F2-silenced cells - EA.hy926 cells model

Endothelial dysfunction in NR2F2-silenced cells - human coronary artery endothelial cells model

Endothelial dysfunction in NR2F2-silenced cells - human lung microvascular endothelial cells model

Gene expression changes in lung cancer cells upon TIGD1 knockdown

Knockdown of MRPL35 promotes cell apoptosis and inhibits cell proliferation in non-small-cell lung cancer

Expression data from whole blood sample of eight kinds of TCM syndromes of rheumatoid arthritis patients.

Expression data from human glioma tissues and corresponding adjacent non-tumor tissues

Expression profiling of CD4+and CD8+ T cells in peripheral blood (PB) of AML patients who were treated with induction chemotherapy plus pomalidomide

Transcriptomic analysis of SiHa cells stably expressing shCtrl or shSYT7

Many heart transplant biopsies currently diagnosed as no rejection have mild molecular antibody-mediated rejection-related changes

SY-1365, a covalent, first in-class CDK7 inhibitor for cancer treatment (microarray mRNA)

SY-1365, a covalent, first in-class CDK7 inhibitor for cancer treatment

Expression data from prostate cancer LNCaP cells in response to Ev or ID1 plasmid overexpression

Global gene expression analysis in NGP CRISPR control cells and NGP ALK(LF655del) cells.

Expression data from human HCC tissues